abstract |
Triazole derivatives and pharmaceutical compositions containing the derivatives are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase AxI. Methods of using tfrs* derivatives in treating diseases or conditions associated with AxI catalytic activity are also disclosed. |